ÂÜÀòÂÒÂ×

Adam Monroe has a diverse work experience in the biotechnology industry. Adam most recently served as President and COO at Zymtronix Inc. starting in November 2022. Prior to that, they were the Chief Executive Officer at Panaceutics Nutrition Inc. from November 2020 to December 2022. Before their CEO role, they worked as a Biotechnology Industry Executive in the consulting field from October 2019 to November 2020. Adam has also held various leadership positions at Novozymes, including President - Americas and Global Sustainability from April 2013 to October 2020, President - Novozymes North America from July 2009 to April 2013, and Director Supply Chain Operations Americas from January 2003 to July 2009.

Adam Monroe attended the University of Arkansas from 1984 to 1988, where they earned a B.S. degree in Chemical Engineering.